Cita APA

Kaoutari, A. E., Fraunhoffer Navarro, N. A., Hoare, O., Teyssedou, C., Soubeyran, P., Gayet, O., . . . Iovanna, J. L. (2021). Metabolomic profiling of pancreatic adenocarcinoma reveals key features driving clinical outcome and drug resistance. Web

Citación estilo Chicago

Kaoutari, Abdessamad El, et al. Metabolomic Profiling of Pancreatic Adenocarcinoma Reveals Key Features Driving Clinical Outcome and Drug Resistance. 2021.

Cita MLA

Kaoutari, Abdessamad El, et al. Metabolomic Profiling of Pancreatic Adenocarcinoma Reveals Key Features Driving Clinical Outcome and Drug Resistance. 2021.